Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108117507B details a green visible-light method for azaspirocyclohexadienone synthesis, offering cost reduction in pharmaceutical intermediate manufacturing and high purity.
Patent CN114232013B reveals a metal-free electrochemical route for indoloquinolines. Discover cost-effective, green manufacturing solutions for high-purity pharmaceutical intermediates.
Optimized synthesis of 2-(4-ethyl-3-iodophenyl)-2-methylpropanoic acid via copper catalysis. Reduces heavy metal residue and cost for API manufacturing.
Novel amide-mediated route for Bempedoic Acid reduces steps and improves purity. Ideal for reliable pharmaceutical intermediate suppliers seeking cost-effective scale-up.
Patent CN111909113A details a metal-free route to 2-substituted benzothiazoles using elemental sulfur, offering significant cost reduction and simplified supply chain management.
Patent CN118307476A reveals a novel nickel-catalyzed synthesis for tetra-substituted olefins using isoprene, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel method for trabectedin intermediate 2 using L-tyrosine. High chiral purity, mild conditions, scalable for API manufacturing.
Patent CN111548325A details a novel synthesis of 7-chloro-benzothiazepine-1,1-dioxide, offering improved yield and halogen introduction for reliable pharmaceutical intermediate supply chains.
Patent CN104926674B details a novel route for Z-unsaturated amides offering safer processing and reduced waste for global pharmaceutical intermediate supply chains.
Novel green nitration process for high-energy azaadamantane derivatives ensuring high purity and reduced waste for reliable supply chain partners.
Patent CN117843613A reveals high-yield synthesis for dabigatran intermediates. Offers cost reduction and supply chain reliability for pharmaceutical manufacturing partners.
Novel aqueous synthesis of diazinium derivatives using phosphotungstic acid. Offers high yield, mild conditions, and cost reduction in API manufacturing for global supply chains.
Patent CN102040614A reveals a water-phase method for Cephalothin Acid, reducing solvent use by over 70% and enhancing safety for API manufacturing supply chains.
Patent CN113200860B reveals high-purity SGLT2 inhibitor intermediate via flow chemistry. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing.
Patent CN113548971A reveals a novel reductive amination route for spermidine. This process offers significant cost reduction and scalability for pharmaceutical intermediate manufacturing.
Patent CN111041515B reveals a metal-free electrochemical route for high-purity quinoxalinone intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN103641879A details a novel chemical route for prednisolone intermediates using plant sterols, offering significant cost reduction and high purity for pharmaceutical manufacturing.
Novel patent CN104193689A offers cost-effective Erlotinib synthesis. Avoids palladium catalysts. Ensures supply chain stability for pharmaceutical intermediates.
Novel patent CN118146139A offers mild conditions for 4-amino-1-methylpiperidine. Reduces cost and supply risk for pharma intermediates manufacturing.
Novel nickel-photocatalyzed method for (R)-1,3-diarylbutene offers mild conditions and high enantioselectivity, ensuring cost-effective supply chain solutions for pharmaceutical intermediates.